Search results for "Amyotrophic lateral sclerosis"

showing 10 items of 228 documents

SERUM CREATINE KINASE LEVEL IN AMYOTROPHIC LATERAL SCLEROSIS: A USEFUL DIAGNOSTIC AID?

2008

...

CK - ALSSettore MED/26 - NeurologiaSERUM CREATINE KINASE AMYOTROPHIC LATERAL SCLEROSIS
researchProduct

Genomic portrait of a sporadic amyotrophic lateral sclerosis case in a large spinocerebellar ataxia type 1 family

2020

Background: Repeat expansions in the spinocerebellar ataxia type 1 (SCA1) gene ATXN1 increases the risk for amyotrophic lateral sclerosis (ALS), supporting a relationship between these disorders. We recently reported the co-existence, in a large SCA1 family, of a clinically definite ALS individual bearing an intermediate ATXN1 expansion and SCA1 patients with a full expansion, some of which manifested signs of lower motor neuron involvement. Methods: In this study, we employed a systems biology approach that integrated multiple genomic analyses of the ALS patient and some SCA1 family members. Results: Our analysis identified common and distinctive candidate genes/variants and related biolog…

Candidate geneSpinocerebellar Ataxia Type 1Medicine (miscellaneous)lcsh:MedicineNetworkBiologyArticle03 medical and health sciences0302 clinical medicinemulti-omics; networkC9orf72medicineCustomized aCGHAmyotrophic lateral sclerosisGene030304 developmental biologyTAF15Genetics0303 health sciencesMulti-omicslcsh:Rmedicine.diseaseAmyotrophic lateral sclerosisPhenotypeSCA1-MNNGSSpinocerebellar ataxiaSpinocerebellar ataxia030217 neurology & neurosurgeryPathway
researchProduct

Importance of Sniff Nasal Pressure (SNIP) as predictor of nocturnal respiratory function in amyotrophic lateral sclerosis (ALS)

2019

Background: In ALS, respiratory disturbances during sleep have an important role in the natural history of the disease. Diurnal and nocturnal blood gases are weakly correlated, but nocturnal respiratory disorders are difficult to predict. Aim: To evaluate if SNIP, an important parameter reflecting respiratory muscle strength, is related to nocturnal respiratory disorders and whether it contributes to predict nocturnal blood gas alterations in addition to daytime blood gas levels in ALS. Methods: Forty patients with ALS, after a daytime respiratory function evaluation, including arterial blood gases and SNIP, underwent a polysomnography with transcutaneous capnography (tcPCO2). The patients …

Capnographymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryPolysomnographyNocturnalmedicine.diseaseInternal medicineparasitic diseasesCardiologyRespiratory muscleMedicineArterial bloodRespiratory functionRespiratory systemAmyotrophic lateral sclerosisbusinessNoninvasive ventilatory support
researchProduct

ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles

2019

Mutations in the FUS gene cause amyotrophic lateral sclerosis (ALS-FUS). Mutant FUS is known to confer cytoplasmic gain of function but its effects in the nucleus are less understood. FUS is an essential component of paraspeckles, subnuclear bodies assembled on a lncRNA NEAT1. Paraspeckles may play a protective role specifically in degenerating spinal motor neurons. However it is still unknown how endogenous levels of mutant FUS would affect NEAT1/paraspeckles. Using novel cell lines with the FUS gene modified by CRISPR/Cas9 and human patient fibroblasts, we found that endogenous levels of mutant FUS cause accumulation of NEAT1 isoforms and paraspeckles. However, despite only mild cytoplasm…

Cell NucleusResearchAmyotrophic Lateral SclerosisIntranuclear Inclusion BodiesNEAT1lcsh:RC346-429Cell LineLoss of Function MutationCell Line TumorFused in sarcoma (FUS)ParaspeckleHumansProtein IsoformsRNA-Binding Protein FUSRNA Long NoncodingAmyotrophic lateral sclerosis (ALS)CRISPR-Cas Systemslcsh:Neurology. Diseases of the nervous systemActa Neuropathologica Communications
researchProduct

Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protei…

2008

Recent studies provide evidence that wild-type Cu/Zn-superoxide dismutase (SOD1(hWT)) might be an important factor in mutant SOD1-mediated amyotrophic lateral sclerosis (ALS). In order to investigate its functional role in the pathogenesis of ALS, we designed fusion proteins of two SOD1 monomers linked by a polypeptide. We demonstrated that wild-type-like mutants, but not SOD1(G85R) homodimers, as well as mutant heterodimers including SOD1(G85R)-SOD1(hWT) display dismutase activity. Mutant homodimers showed an increased aggregation compared with the corresponding heterodimers in cell cultures and transgenic Caenorhabditis elegans, although SOD1(G85R) heterodimers are more toxic in functiona…

Cell SurvivalRecombinant Fusion Proteinsanimal diseasesSOD1MutantProtein aggregationAnimals Genetically ModifiedProtein CarbonylationSuperoxide dismutaseMicechemistry.chemical_compoundSuperoxide Dismutase-1Cell Line TumorGeneticsAnimalsHumansAmino Acid SequenceCaenorhabditis elegansMolecular BiologyGenetics (clinical)Motor NeuronsbiologySuperoxide DismutaseSuperoxideAmyotrophic Lateral SclerosisWild typenutritional and metabolic diseasesHydrogen PeroxideGeneral MedicineFusion proteinProtein Structure Tertiarynervous system diseasesCell biologyAmino Acid Substitutionnervous systemchemistryBiochemistrybiology.proteinDismutaseDimerizationHuman Molecular Genetics
researchProduct

Elevated cerebrospinal fluid and plasma homocysteine levels in ALS

2009

BACKGROUND: High cerebrospinal fluid (CSF) and plasma levels of homocysteine (HC) have been reported in certain neurodegenerative disorders, such as Alzheimer's, Parkinson's diseases and, recently, amyotrophic lateral sclerosis (ALS). OBJECTIVES: To assay the CSF and plasma levels of HC in ALS patients and controls, and to evaluate the relationship between HC levels and clinical variables of the disease. METHODS: Cerebrospinal fluid from sixty-nine (M/F 1.87) and plasma from sixty-five ALS patients (M/F 1.83) were taken and stored at -80 degrees C until use. Controls (CSF = 55; plasma = 67) were patients admitted to our hospital for neurological disorders with no known relationship to HC ch…

Central Nervous SystemMaleAmyotrophic Lateral SclerosisHyperhomocysteinemiaComorbidityMiddle Agedcerebrospinal fluidPredictive Value of TestsHumansamyotrophic lateral sclerosiSettore MED/26 - NeurologiaFemaleHomocysteineplasmaBiomarkersAged
researchProduct

Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation

2021

AbstractPost-translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), the RNA-binding protein TDP-43, is hyperphosphorylated in disease on several C-terminal serine residues, which is generally believed to promote TDP-43 aggregation. Here, we show that hyperphosphorylation by Casein kinase 1δ or C-terminal phosphomimetic mutations surprisingly reduce TDP-43 phase separation and aggregation and render TDP-43 condensates more liquid-like and dynamic. Multi-scale simulations revea…

Chemistrynutritional and metabolic diseasesHyperphosphorylationRNAProtein aggregationmedicine.diseasenervous system diseasesCell biologySerinemental disordersOrganellemedicineCasein kinase 1Nuclear transportAmyotrophic lateral sclerosis
researchProduct

Reply to Dr Michaudet al.

2015

There is no abstract

Cholagogues and Cholereticsbusiness.industryEndoplasmic reticulumAmyotrophic Lateral SclerosisTaurochenodeoxycholic acidTauroursodeoxycholic acidMitochondrionPharmacologyEndoplasmic Reticulummedicine.diseaseTaurochenodeoxycholic Acidchemistry.chemical_compoundNeurologychemistryImmunologyUnfolded Protein ResponsemedicineUnfolded protein responseAnimalsHumansTUDCA ALSSettore MED/26 - NeurologiaNeurology (clinical)Amyotrophic lateral sclerosisbusinessEuropean Journal of Neurology
researchProduct

THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS

2015

We report a patient with bulba r - onset, clinically defined, sporadic amyotrophic lateral sclerosis bearing an isolated syringomyelia of the lower thoracic portion of the spinal cord. This is a very unusual association between two rare and progressive disorders, both affecting the spinal motoneurons. Syringomyelia might have acted as a phenotypic modifier in this ALS patient.

Community and Home Caremedicine.medical_specialtybusiness.industrymedicine.diseasePhenotypic modifierSpinal cordSurgerymedicine.anatomical_structureALS syringomyelia case reportmedicineSettore MED/26 - NeurologiaAmyotrophic lateral sclerosisbusinessSyringomyelia
researchProduct

Augmentative Alternative Communication using Eyelid Movement Remote Detection by Speckle Patterns Tracking System for Amyotrophic Lateral Sclerosis D…

2017

The implementation of augmentative alternative communication optical device for ALS speech problem is presented. The sensor is based on temporal tracking of back-reflected secondary speckle patterns generated when illuminating an eyelid with a laser.

Computer sciencebusiness.industryComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONEye movementTracking systemmedicine.diseaseSpeckle patternmedicine.anatomical_structuremedicineComputer visionEyelidSpeckle imagingArtificial intelligenceImage sensorAmyotrophic lateral sclerosisbusinessAugmentativeOptics in the Life Sciences Congress
researchProduct